Related Experiment Video
Updated: Jul 30, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
HIV-associated nephropathy: an urban epidemic
M Monahan1, N Tanji, P E Klotman
1Division of Nephrology, the Mt. Sinai School of Medicine, New York, NY 10029, USA.
Human immunodeficiency virus-associated nephropathy (HIVAN) is a major kidney disease in HIV-1 patients, especially African Americans. Improved treatments are increasing HIVAN prevalence in end-stage renal disease populations.
Area of Science:
- Nephrology
- Infectious Diseases
- Public Health
Background:
- Human immunodeficiency virus-associated nephropathy (HIVAN) is the predominant chronic kidney disease in HIV-1-seropositive individuals.
- HIVAN disproportionately affects African Americans, representing the third leading cause of end-stage renal disease (ESRD) in this demographic (ages 20-64).
- The incidence of HIVAN correlates with AIDS epidemic trends, suggesting a growing patient pool at risk.
Purpose of the Study:
- To analyze the current epidemiology and projected trends of HIVAN.
- To understand the impact of improved patient survival and treatment modalities on HIVAN prevalence within ESRD and pre-ESRD populations.
Main Methods:
- Epidemiological analysis of HIVAN incidence and its correlation with HIV/AIDS demographics.
- Review of treatment outcomes for HIVAN, including highly active antiretroviral therapy (HAART) and angiotensin-converting enzyme (ACE)-inhibitors.
- Assessment of survival rates for HIV-1-seropositive patients undergoing hemodialysis.
Main Results:
- HIVAN incidence rates have mirrored changes in AIDS incidence.
- Urban nephrology centers are expected to manage increasing numbers of HIVAN cases.
- Enhanced survival rates and effective treatments (HAART, ACE-inhibitors) are leading to a higher prevalence of HIVAN among ESRD and pre-ESRD patients.
Conclusions:
- HIVAN remains a significant public health concern, particularly within specific demographic groups.
- Advances in HIV/AIDS care are altering the clinical landscape of HIVAN, necessitating proactive management strategies.
- Nephrology centers must prepare for a growing prevalence of HIVAN in patients with chronic kidney disease.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Nephrotic Syndrome I : Introduction
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Diabetic Nephropathy

